Literature DB >> 8091951

Regional differences in bromodeoxyuridine uptake, expression of Ki-67 protein, and nucleolar organizer region counts in glioblastoma multiforme.

K Onda1, R L Davis, C B Wilson, T Hoshino.   

Abstract

To investigate intratumoral differences in indices of tumor cell proliferation, we measured the bromodeoxyuridine labeling index (BrdUrd LI), the Ki-67 protein proliferating cell indices (PCIs) determined by monoclonal antibody MIB 1 in microwave-processed paraffin sections (MIB 1 PCI) and in some cases by monoclonal antibody in frozen sections (Ki-67 PCI), and counts of argyrophilic nucleolar organizer regions (AgNORs) in 20 glioblastomas. In the most actively proliferating areas, MIB 1 and Ki-67 PCIs correlated well with the BrdUrd LI and with each other, while AgNOR counts correlated less strongly with these indices. In less active areas, the MIB 1 PCI and BrdUrd LI changed concomitantly from one area to another within a tumor except in areas of pseudopalisading with necrosis; in these areas the BrdUrd LI decreased significantly compared with neighboring tumor tissue, while the MIB 1 PCI did not. There was very little staining of gemistocytic nuclei with either anti-BrdUrd or MIB 1 monoclonal antibodies; this supports the concept that gemistocytes are mainly quiescent cells. AgNORs in all of the above-mentioned areas varied from tumor to tumor, which suggests that they may indicate some cellular activity other than proliferation. The close correlation between the BrdUrd LI and Ki-67 protein PCIs in corresponding regions of glioblastomas suggests that MIB 1 staining of microwave-processed paraffin sections can be used to evaluate the growth potential of individual glioblastomas and possibly of other gliomas as well.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8091951     DOI: 10.1007/bf00293319

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  45 in total

1.  The use of the monoclonal antibody Ki-67 in the identification of proliferating cells: application to surgical neuropathology.

Authors:  P C Burger; T Shibata; P Kleihues
Journal:  Am J Surg Pathol       Date:  1986-09       Impact factor: 6.394

2.  Controlled silver-staining of nucleolus organizer regions with a protective colloidal developer: a 1-step method.

Authors:  W M Howell; D A Black
Journal:  Experientia       Date:  1980-08-15

3.  Prognostic implications of the proliferative potential of low-grade astrocytomas.

Authors:  T Hoshino; L A Rodriguez; K G Cho; K S Lee; C B Wilson; M S Edwards; V A Levin; R L Davis
Journal:  J Neurosurg       Date:  1988-12       Impact factor: 5.115

4.  Proliferating cell nuclear antigen and Ki-67 immunohistochemistry in brain tumors: a comparative study.

Authors:  D N Louis; S Edgerton; A D Thor; E T Hedley-Whyte
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

5.  Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation.

Authors:  J Gerdes; U Schwab; H Lemke; H Stein
Journal:  Int J Cancer       Date:  1983-01-15       Impact factor: 7.396

6.  Transferrin receptor in normal and neoplastic brain tissue: implications for brain-tumor immunotherapy.

Authors:  L Recht; C O Torres; T W Smith; V Raso; T W Griffin
Journal:  J Neurosurg       Date:  1990-06       Impact factor: 5.115

7.  Nucleolar organiser regions in normal, cirrhotic, and carcinomatous livers.

Authors:  J Crocker; J McGovern
Journal:  J Clin Pathol       Date:  1988-10       Impact factor: 3.411

8.  Proliferative characteristics of juvenile pilocytic astrocytomas determined by bromodeoxyuridine labeling.

Authors:  S Ito; T Hoshino; M Shibuya; M D Prados; M S Edwards; R L Davis
Journal:  Neurosurgery       Date:  1992-09       Impact factor: 4.654

9.  Immunohistochemical detection of proliferating cell nuclear antigen in solid human malignancies.

Authors:  B A Robbins; D de la Vega; K Ogata; E M Tan; R M Nakamura
Journal:  Arch Pathol Lab Med       Date:  1987-09       Impact factor: 5.534

10.  Immunohistochemical demonstration of DNA polymerase alpha in human brain-tumor cells.

Authors:  K Kunishio; N Mishima; T Matsuhisa; K Tsuno; N Matsumi; T Satoh; K Matsumoto; T Furuta; A Nishimoto; T Shiraishi
Journal:  J Neurosurg       Date:  1990-02       Impact factor: 5.115

View more
  9 in total

Review 1.  Can neural stem cells be used to track down and destroy migratory brain tumor cells while also providing a means of repairing tumor-associated damage?

Authors:  M Noble
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-07       Impact factor: 11.205

2.  Gemistocytes in astrocytomas: are they a significant prognostic factor?

Authors:  Dely C Martins; Suzana M Malheiros; Lucila H Santiago; João N Stávale
Journal:  J Neurooncol       Date:  2006-04-28       Impact factor: 4.130

Review 3.  Definition and diagnostic implications of gemistocytic astrocytomas: a pathological perspective.

Authors:  Tarik Tihan; Poonam Vohra; Mitchel S Berger; G Evren Keles
Journal:  J Neurooncol       Date:  2006-01       Impact factor: 4.130

4.  Proliferation markers in gliomas: a comparison of BUDR, KI-67, and MIB-1.

Authors:  R L Davis; K Onda; M Shubuya; K Lamborn; T Hoshino
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

5.  Proliferating cell nuclear antigen (PCNA) and Ki-67 immunopositivity in human astrocytic tumours.

Authors:  R Kordek; W Biernat; J Alwasiak; P P Liberski
Journal:  Acta Neurochir (Wien)       Date:  1996       Impact factor: 2.216

6.  The proliferative potential of the pilocytic astrocytoma: the relation between MIB-1 labeling and clinical and neuro-radiological follow-up.

Authors:  C M Dirven; J Koudstaal; J J Mooij; W M Molenaar
Journal:  J Neurooncol       Date:  1998-03       Impact factor: 4.130

7.  Comparison of bromodeoxyuridine uptake and MIB 1 immunoreactivity in medulloblastomas determined with single and double immunohistochemical staining methods.

Authors:  K Onda; R L Davis; M S Edwards
Journal:  J Neurooncol       Date:  1996-08       Impact factor: 4.130

8.  Telomerase expression shows differences across multiple regions of oligodendroglioma versus high grade astrocytomas but shows correlation with Mib-1 labelling.

Authors:  B K Kleinschmidt-DeMasters; T L Hashizumi; C I Sze; K O Lillehei; A L Shroyer; K R Shroyer
Journal:  J Clin Pathol       Date:  1998-04       Impact factor: 3.411

9.  Prognostic indicators in a range of astrocytic tumours: an immunohistochemical study with Ki-67 and p53 antibodies.

Authors:  D W Ellison; P V Steart; A C Bateman; R M Pickering; J D Palmer; R O Weller
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-10       Impact factor: 10.154

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.